| Mrs Trari Bowdish, CRNA | |
|
700 Cooper Ave, Saginaw, MI 48602-5383 | |
| (989) 583-0000 | |
| Not Available |
| Full Name | Mrs Trari Bowdish |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 9 Years |
| Location | 700 Cooper Ave, Saginaw, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043688815 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 4704258148 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Covenant Medical Center | Saginaw, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Covenant Medical Center Inc | 2769387778 | 380 |
News Archive
According to an open-access Editor's Choice article in ARRS' American Journal of Roentgenology (AJR), post-neoadjuvant therapy (NAT) changes in metabolic metrics from PET/MRI and morphologic metrics from CT were associated with pathologic response and overall survival in patients with pancreatic ductal adenocarcinoma (PDA).
A new technique developed by a Binghamton University physicist and his colleagues will improve the quality of flexible, conductive, transparent glass. (The sort that's needed for Minority Report-style giant computer displays.)
In a study that began in a pair of infant siblings with a rare heart defect, Johns Hopkins researchers say they have identified a key molecular switch that regulates heart cell division and normally turns the process off around the time of birth. Their research, they report, could advance efforts to turn the process back on and regenerate heart tissue damaged by heart attacks or disease.
New chemotherapy agents appear associated with improvements in survival time for patients with metastastic colorectal cancer, but at substantial cost, according to a report in the March 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Chemical engineers from Johns Hopkins University have broken the "mucus barrier," engineering the first drug-delivery particles capable of passing through human mucus - regarded by many as nearly impenetrable - and carrying medication that could treat a range of diseases. Those conditions include lung cancer, cervical cancer and cystic fibrosis, the research noted in a presentation scheduled for the 236th National Meeting of the American Chemical Society.
› Verified 9 days ago
| Entity Name | Covenant Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225151897 PECOS PAC ID: 2769387778 Enrollment ID: O20040209001142 |
News Archive
According to an open-access Editor's Choice article in ARRS' American Journal of Roentgenology (AJR), post-neoadjuvant therapy (NAT) changes in metabolic metrics from PET/MRI and morphologic metrics from CT were associated with pathologic response and overall survival in patients with pancreatic ductal adenocarcinoma (PDA).
A new technique developed by a Binghamton University physicist and his colleagues will improve the quality of flexible, conductive, transparent glass. (The sort that's needed for Minority Report-style giant computer displays.)
In a study that began in a pair of infant siblings with a rare heart defect, Johns Hopkins researchers say they have identified a key molecular switch that regulates heart cell division and normally turns the process off around the time of birth. Their research, they report, could advance efforts to turn the process back on and regenerate heart tissue damaged by heart attacks or disease.
New chemotherapy agents appear associated with improvements in survival time for patients with metastastic colorectal cancer, but at substantial cost, according to a report in the March 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Chemical engineers from Johns Hopkins University have broken the "mucus barrier," engineering the first drug-delivery particles capable of passing through human mucus - regarded by many as nearly impenetrable - and carrying medication that could treat a range of diseases. Those conditions include lung cancer, cervical cancer and cystic fibrosis, the research noted in a presentation scheduled for the 236th National Meeting of the American Chemical Society.
› Verified 9 days ago
| Entity Name | Ascension St. Mary's Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457306185 PECOS PAC ID: 6305737156 Enrollment ID: O20040322001854 |
News Archive
According to an open-access Editor's Choice article in ARRS' American Journal of Roentgenology (AJR), post-neoadjuvant therapy (NAT) changes in metabolic metrics from PET/MRI and morphologic metrics from CT were associated with pathologic response and overall survival in patients with pancreatic ductal adenocarcinoma (PDA).
A new technique developed by a Binghamton University physicist and his colleagues will improve the quality of flexible, conductive, transparent glass. (The sort that's needed for Minority Report-style giant computer displays.)
In a study that began in a pair of infant siblings with a rare heart defect, Johns Hopkins researchers say they have identified a key molecular switch that regulates heart cell division and normally turns the process off around the time of birth. Their research, they report, could advance efforts to turn the process back on and regenerate heart tissue damaged by heart attacks or disease.
New chemotherapy agents appear associated with improvements in survival time for patients with metastastic colorectal cancer, but at substantial cost, according to a report in the March 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Chemical engineers from Johns Hopkins University have broken the "mucus barrier," engineering the first drug-delivery particles capable of passing through human mucus - regarded by many as nearly impenetrable - and carrying medication that could treat a range of diseases. Those conditions include lung cancer, cervical cancer and cystic fibrosis, the research noted in a presentation scheduled for the 236th National Meeting of the American Chemical Society.
› Verified 9 days ago
| Entity Name | Matrix Anesthesia Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386922268 PECOS PAC ID: 9830360544 Enrollment ID: O20110928000671 |
News Archive
According to an open-access Editor's Choice article in ARRS' American Journal of Roentgenology (AJR), post-neoadjuvant therapy (NAT) changes in metabolic metrics from PET/MRI and morphologic metrics from CT were associated with pathologic response and overall survival in patients with pancreatic ductal adenocarcinoma (PDA).
A new technique developed by a Binghamton University physicist and his colleagues will improve the quality of flexible, conductive, transparent glass. (The sort that's needed for Minority Report-style giant computer displays.)
In a study that began in a pair of infant siblings with a rare heart defect, Johns Hopkins researchers say they have identified a key molecular switch that regulates heart cell division and normally turns the process off around the time of birth. Their research, they report, could advance efforts to turn the process back on and regenerate heart tissue damaged by heart attacks or disease.
New chemotherapy agents appear associated with improvements in survival time for patients with metastastic colorectal cancer, but at substantial cost, according to a report in the March 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Chemical engineers from Johns Hopkins University have broken the "mucus barrier," engineering the first drug-delivery particles capable of passing through human mucus - regarded by many as nearly impenetrable - and carrying medication that could treat a range of diseases. Those conditions include lung cancer, cervical cancer and cystic fibrosis, the research noted in a presentation scheduled for the 236th National Meeting of the American Chemical Society.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Trari Bowdish, CRNA 1447 N Harrison St, Saginaw, MI 48602-4727 Ph: (989) 583-0000 | Mrs Trari Bowdish, CRNA 700 Cooper Ave, Saginaw, MI 48602-5383 Ph: (989) 583-0000 |
News Archive
According to an open-access Editor's Choice article in ARRS' American Journal of Roentgenology (AJR), post-neoadjuvant therapy (NAT) changes in metabolic metrics from PET/MRI and morphologic metrics from CT were associated with pathologic response and overall survival in patients with pancreatic ductal adenocarcinoma (PDA).
A new technique developed by a Binghamton University physicist and his colleagues will improve the quality of flexible, conductive, transparent glass. (The sort that's needed for Minority Report-style giant computer displays.)
In a study that began in a pair of infant siblings with a rare heart defect, Johns Hopkins researchers say they have identified a key molecular switch that regulates heart cell division and normally turns the process off around the time of birth. Their research, they report, could advance efforts to turn the process back on and regenerate heart tissue damaged by heart attacks or disease.
New chemotherapy agents appear associated with improvements in survival time for patients with metastastic colorectal cancer, but at substantial cost, according to a report in the March 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Chemical engineers from Johns Hopkins University have broken the "mucus barrier," engineering the first drug-delivery particles capable of passing through human mucus - regarded by many as nearly impenetrable - and carrying medication that could treat a range of diseases. Those conditions include lung cancer, cervical cancer and cystic fibrosis, the research noted in a presentation scheduled for the 236th National Meeting of the American Chemical Society.
› Verified 9 days ago
Theresa L Jones, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1447 N Harrison St, Saginaw, MI 48602 Phone: 989-583-0000 | |
William J Zwiers, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 700 Cooper Ave, Saginaw, MI 48602 Phone: 989-583-6200 | |
Mr. Michael Dennis Romanow, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1447 N Harrison St, Saginaw, MI 48602 Phone: 989-583-2794 | |
Christine Ann Smith, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1447 N Harrison St, Saginaw, MI 48602 Phone: 989-583-4673 Fax: 989-583-4635 | |
Lynn Ann Barnhart, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 700 Cooper Ave, Saginaw, MI 48602 Phone: 989-258-1003 | |
Jesse L Mcdonald, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1447 N Harrison St, Saginaw, MI 48602 Phone: 989-583-4114 Fax: 989-583-1349 |